Search Results - "Grewal, Ravinder"

Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer by Ho, Alan L, Grewal, Ravinder K, Leboeuf, Rebecca, Sherman, Eric J, Pfister, David G, Deandreis, Desiree, Pentlow, Keith S, Zanzonico, Pat B, Haque, Sofia, Gavane, Somali, Ghossein, Ronald A, Ricarte-Filho, Julio C, Domínguez, José M, Shen, Ronglai, Tuttle, R. Michael, Larson, Steve M, Fagin, James A

“…Inhibition of mitogen-activated protein kinase resulted in an increase in expression of the sodium–iodide symporter in 12 of 20 patients, 8 of whom had…”
Get full text

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers by Dunn, Lara A, Sherman, Eric J, Baxi, Shrujal S, Tchekmedyian, Vatche, Grewal, Ravinder K, Larson, Steven M, Pentlow, Keith S, Haque, Sofia, Tuttle, R Michael, Sabra, Mona M, Fish, Stephanie, Boucai, Laura, Walters, Jamie, Ghossein, Ronald A, Seshan, Venkatraman E, Ni, Ai, Li, Duan, Knauf, Jeffrey A, Pfister, David G, Fagin, James A, Ho, Alan L

“…Abstract Context BRAFV600E mutant thyroid cancers are often refractory to radioiodine (RAI). Objectives To investigate the utility and molecular underpinnings…”
Get full text

Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy by Boucai, Laura, Saqcena, Mahesh, Kuo, Fengshen, Grewal, Ravinder K, Socci, Nicholas, Knauf, Jeffrey A, Krishnamoorthy, Gnana P, Ryder, Mabel, Ho, Alan L, Ghossein, Ronald A, Morris, Luc G T, Seshan, Venkatraman, Fagin, James A

“…The determinants of response or resistance to radioiodine (RAI) are unknown. We aimed to identify genomic and transcriptomic factors associated with structural…”
Get full text

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study by Moskowitz, Alison J, Dr, Schöder, Heiko, Prof, Yahalom, Joachim, Prof, McCall, Susan J, NP, Fox, Stephanie Y, BS, Gerecitano, John, MD, Grewal, Ravinder, MD, Hamlin, Paul A, MD, Horwitz, Steven, MD, Kobos, Rachel, MD, Kumar, Anita, MD, Matasar, Matthew, MD, Noy, Ariela, MD, Palomba, M Lia, MD, Perales, Miguel-Angel, MD, Portlock, Carol S, Prof, Sauter, Craig, MD, Shukla, Neerav, MD, Steinherz, Peter, Prof, Straus, David, Prof, Trippett, Tanya, MD, Younes, Anas, Prof, Zelenetz, Andrew, Prof, Moskowitz, Craig H, Prof

“…Summary Background Pre-transplantation18 F-fluorodeoxyglucose (FDG) PET-negativity is one of the strongest predictors of outcome after high-dose therapy and…”
Get full text

Enhancing Radioiodine Incorporation in BRAF -Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial by Tchekmedyian, Vatche, Dunn, Lara, Sherman, Eric, Baxi, Shrujal S, Grewal, Ravinder K, Larson, Steven M, Pentlow, Keith S, Haque, Sofia, Tuttle, R Michael, Sabra, Mona M, Fish, Stephanie, Boucai, Laura, Walters, Jamie, Ghossein, Ronald A, Seshan, Venkatraman E, Knauf, Jeffrey A, Pfister, David G, Fagin, James A, Ho, Alan L

“…Oncogenic activation of mitogen-activated protein kinase (MAPK) signaling is associated with radioiodine refractory (RAIR) thyroid cancer. Preclinical models…”
Get more information

Novel Approaches to Thyroid Cancer Treatment and Response Assessment by Grewal, Ravinder K., MD, Ho, Alan, MD, PhD, Schöder, Heiko, MD

“…The incidence of thyroid cancer has been increasing. After total thyroidectomy of well-differentiated thyroid tumors with intermediate- or high-risk features…”
Get full text

Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning by Robbins, Richard J., Wan, Qiang, Grewal, Ravinder K., Reibke, Roland, Gonen, Mithat, Strauss, H. William, Tuttle, R. Michael, Drucker, William, Larson, Steven M.

“…Context/Objective: Approximately 15% of thyroid cancer patients develop subsequent metastases. The clinical course of patients with metastatic thyroid…”
Get full text

Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management by Mahajan, Sonia, Grewal, Ravinder K., Friedman, Kent P., Schöder, Heiko, Pandit-Taskar, Neeta

“…•The United States food and drug administration has recently granted approval to the targeted 177Lu-PSMA-617 therapy in prostate cancer patients.•Salivary…”
Get full text

A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated thyroid cancer patients by Robenshtok, Eyal, Grewal, Ravinder K, Fish, Stephanie, Sabra, Mona, Tuttle, R Michael

“…Postsurgical thyrotropin (TSH)-stimulated serum thyroglobulin (Tg) level can be used to predict the likelihood of finding radioactive iodine (RAI) avid…”
Get more information

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma by Soumerai, Jacob D., Rosenthal, Allison, Harkins, Shannon, Duffy, Jessica, Mecca, Carmen, Wang, Yingbing, Grewal, Ravinder K., El-Jawahri, Areej R., Liu, Huiyun, Menard, Cedric, Dogan, Ahmet, Yang, Lei, Rimsza, Lisa M., Bantilan, Kurt, Martin, Haley, Lei, Matthew, Mohr, Sydney, Kurilovich, Anna, Kudryashova, Olga, Postovalova, Ekaterina, Nardi, Valentina, Abramson, Jeremy S., Chiarle, Roberto, Zelenetz, Andrew D., Louissaint, Abner

Get full text

Interobserver agreement of 18F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism by Robin, Philippe, Grewal, Ravinder K., Le Roux, Pierre-Yves, Le Gal, Grégoire, Salaun, Pierre-Yves

Get full text

Incidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases by Mahajan, Sonia, Shaha, Ashok, Grewal, Ravinder K

“…ABSTRACTGa-DOTATATE, a positron-emitting somatostatin analog, has been approved by the Food and Drug Administration for imaging neuroendocrine tumors (NETs)…”
Get full text

Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE by Raj, Nitya, Coffman, Kelley, Le, Tiffany, Do, Richard Kinh Gian, Rafailov, Johnathan, Choi, Ye, Chou, Joanne F, Capanu, Marinela, Dunphy, Mark, Fox, Josef J, Grewal, Ravinder K, Reddy, Ryan P, Riedl, Christopher, Schoder, Heiko, Bodei, Lisa, Reidy-Lagunes, Diane

“…Lutetium-177 (177Lu)-DOTATATE received FDA approval in 2018 to treat somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (NETs). Little…”
Get more information

Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs by Bodei, Lisa, Michael Tuttle, R., Grewal, Ravinder K., Mauguen, Audrey, Augensen, Finn, Abusamra, Murad, Mahajan, Sonia, Jayaprakasam, Vetri Sudar, Osborne, Joseph R., Haque, Sofia, Wong, Bernadette Z. Y., Ghossein, Ronald A., Fagin, James, Schӧder, Heiko, Ho, Alan, Humm, John L., Larson, Steven M.

Get full text

The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients by Mauguen, Audrey, Grewal, Ravinder K., Augensen, Finn, Abusamra, Murad, Mahajan, Sonia, Jayaprakasam, Vetri Sudar, Osborne, Joseph, Haque, Sofia, Wong, Bernadette Z. Y., Ghossein, Ronald A., Fagin, James, Schӧder, Heiko, Tuttle, R. Michael, Ho, Alan, Humm, John L., Larson, Steven M.

“…Purpose To introduce a biomarker-based dosimetry method for the rational selection of a treatment activity for patients undergoing radioactive iodine 131 I…”
Get full text

Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolism by Lu, Yang, Lorenzoni, Alice, Fox, Josef J, Rademaker, Jürgen, Vander Els, Nicholas, Grewal, Ravinder K, Strauss, H William, Schöder, Heiko

“…Standard ventilation and perfusion (V˙/Q˙) scintigraphy uses planar images for the diagnosis of pulmonary embolism (PE). To evaluate whether tomographic…”
Get full text

Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases by Sabra, Mona M, Grewal, Ravinder K, Ghossein, Ronald A, Tuttle, R Michael

“…While radioactive iodine (RAI) adjuvant therapy is commonly recommended for most papillary thyroid cancer patients presenting with large volume nodal…”
Get more information

Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence by Hugo, Jonathan, Robenshtok, Eyal, Grewal, Ravinder, Larson, Steve, Tuttle, R Michael

“…Multiple studies have demonstrated successful radioactive iodine remnant ablation (RRA) following preparation with recombinant human thyroid stimulating…”
Get more information

Enchondroma of Tibia as Potential False-positive Finding on 68Ga-DOTATOC PET/CT Scan by Mahajan, Sonia, Bodei, Lisa, Huicochea Castellanos, Sandra, Grewal, Ravinder K

“…ABSTRACTA 70-year-old man with a history of carcinoid tumor of small bowel was referred for Ga-DOTATOC study to evaluate the extent of disease. PET/CT scan…”
Get full text

Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET by Yeung, Henry W D, Grewal, Ravinder K, Gonen, Mithat, Schöder, Heiko, Larson, Steven M

“…The routine use of PET/CT fusion imaging in a large oncology practice has led to the realization that (18)F-FDG uptake into normal fat and muscle can be a…”
Get full text